Regulatory

>

Latest News

FDA Updates Prescribing Information for Bristol Myers Squibb’s Camzyos to Reduce Echocardiography Monitoring Requirements
FDA Updates Prescribing Information for Bristol Myers Squibb’s Camzyos to Reduce Echocardiography Monitoring Requirements

April 21st 2025

The simplified requirements for Camzyos are expected to ease prior contraindications, thereby simplifying treatment and expanding eligibility in patients with symptomatic New York Heart Association Class II-III obstructive hypertrophic cardiomyopathy.

Regeneron, Sanofi Get FDA Approval for Dupixent to Treat Chronic Spontaneous Urticaria
Regeneron, Sanofi Get FDA Approval for Dupixent to Treat Chronic Spontaneous Urticaria

April 18th 2025

FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion
FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion

April 18th 2025

Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines

April 18th 2025

Bringing Biotech Innovation Across Borders
Bringing Biotech Innovation Across Borders

April 17th 2025